Pharmaceutical Technology

JULY 14, 2022

Historically, the pharmaceutical industry has failed to meet the needs of this patient population. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients. Efforts have been made to change this.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

pharmaphorum

NOVEMBER 19, 2021

Roche’s oral treatment Evrysdi for the rare genetic disease spinal muscular atrophy (SMA) will be made available on the NHS in England, after NICE reached a three-year access agreement with the company. million price tag make it is the most expensive treatment ever approved for NHS funding.

98

98

Digital Pharmacist

MARCH 28, 2024

Educate Your Staff on Parkinson’s Disease Pharmacists are a constant in the lives of patients living with Parkinson’s Disease. Parkinson’s patients and their caregivers are going to be frequent customers at your pharmacy, so it is important for your staff to understand the disease they’re faced with and the medications used to treat it.

Health and Personal Care Stores 68

Health and Personal Care Stores Hospitals Pharmacy Management 68

Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. The three agreed on a confidential price, and the TLV determined whether the drug was cost effective for the eligible patient population. million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

105

105

pharmaphorum

APRIL 20, 2021

According to Novartis, Kesimpta is the first targeted B cell therapy for RMS that can be self-administered at home once a month using an autoinjector, avoiding the need for patients to travel to hospital during the pandemic, and easing the pressure on clinicians. billion by 2028.

Hospitals 111

Hospitals Documentation 111

pharmaphorum

JANUARY 21, 2022

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry. WHO is OMI?

Vaccines 52

Vaccines 52

pharmaphorum

NOVEMBER 16, 2021

NHS patients in England and Wales with drug-resistant epilepsy are in line for access to another treatment option, after NICE recommended routine use of Angelini group company Arvelle Pharma’s Ontozry. The drug was eventually cleared in the EU in April, with the UK giving it a green light in June.

Documentation 96

Documentation 96

pharmaphorum

OCTOBER 21, 2021

As it turned out, Aduhelm (aducanumab) made just $300,000 in the three-month period from July to September, against analysts’ estimates of $12 million, suggesting that few patients are being treated with the $56,000 a year therapy. Biogen reported $1.6 million in sales for the drug in the second quarter.

120

120

Pharmaceutical Technology

MAY 2, 2023

Immuno-oncology (IO) agents have transformed the cancer therapeutics landscape, driving long-term remissions in a subset of patients who historically had limited options. Although a subset of patients derives long-term benefits from IO therapies, a high percentage of patients still fail to respond or develop resistance to IO therapy.

Immunity 52

Immunity Immunization Vaccines 52

Pharmaceutical Technology

APRIL 5, 2023

More than a decade after the first patient was treated with a CAR-T therapy, six therapies relying on the same principles have been approved by the US Food and Drug Administration (FDA) and marketed to thousands of patients. AZ: What is the ISCT doing to tackle supply and access-related obstacles in the CAR-T field?

Immunity 59

Immunity Immunization 59

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Engagement channels. Regulated industry learnings.

Communication 92

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 92

pharmaphorum

SEPTEMBER 15, 2020

The huge rise in the use of telemedicine services during lockdown has brought care directly to patients in their homes, while pharma’s communications with healthcare professionals (HCPs) has experienced a similar push to digital channels. Jeremy Richter, Tag. We’re all trying to find ways to automate. About the interviewees.

Communication 119

Communication Documentation Labelling Vaccines 119

pharmaphorum

JUNE 8, 2021

The FDA “has failed in its responsibility to protect patients and families from unproven treatments with known harms” in approving Biogen’s Alzheimer’s disease drug Aduhelm. ICER points to brain swelling and potential bleeding seen in approximately 30% of patients treated with aducanumab. Broad label questioned.

Labelling 98

Labelling Drug Pricing 98

pharmaphorum

NOVEMBER 24, 2021

reSET-O was the first prescription DTx ever to win a breakthrough device designation from the FDA, according to Pear , allowing it to tap into a programme intended to speed up the development and regulatory review of new therapies so they can reach patients sooner. Photo by thom masat on Unsplash.

59

59

Citus Health Specialty Pharmacy

MARCH 3, 2021

Innovative specialty pharmacy provider for hemophiliac and bleeding disorder patients to implement Citus Health’s HIPAA-compliant digital health solution suite to improve patient and staff communications, therapy adherence rates and patient outcomes.

Specialty Pharmacies 52

Specialty Pharmacies Communication HIPAA 52

Pharmaceutical Technology

JUNE 29, 2022

Additionally, pricing and access for rare disease therapies continue to be scrutinized closely. Others judge its success based on the fact that 95% of rare diseases still have no available therapies and patient needs remain unmet. of the total patient population suffering from rare diseases. Approximately 10.9%

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Drug Development 98

pharmaphorum

JUNE 2, 2021

NICE has rejected routine NHS funding for Roche’s Evrysdi (risdiplam) for spinal muscular atrophy drug in draft guidance, a decision which doesn’t come as a surprise to patient association SMA UK. The post NICE ‘no’ to Roche’s risdiplam for SMA not unexpected, says patient group appeared first on.

Documentation 52

Documentation Communication 52

Proxsys Rx

SEPTEMBER 12, 2022

According to the National Association of Specialty Pharmacy , a specialty pharmacy is a state-licensed pharmacy that either solely, or primarily, provides medications for patients with serious, chronic health conditions requiring complex therapies. What is a Specialty Pharmacy?

Specialty Pharmacies 52

Specialty Pharmacies Hospitals 52

epicur

DECEMBER 7, 2023

In this blog post, we’ll take a deeper look at the essentials of inventory management tailored specifically for veterinary practices—demand forecasting, the importance of streamlined systems and workflows, organization tips, and finding the perfect balance between practice needs and patient care. Let’s dive in!

Inventory Audits 52

Inventory Audits Labelling Hospitals Compounding 52

epicur

MAY 16, 2024

You may know him from his popular Instagram account @theveteyeguy, where he provides accessible information on veterinary ophthalmology for veterinarians and owners alike. How does improving veterinarians’ knowledge of ophthalmology benefit patient care overall? So you have that answer before the patient leaves.

Compounding 52

Compounding Hospitals 52

RX Note

NOVEMBER 13, 2023

accessibility to customers and transportation) Useful to be in or near major business district, making it a high-traffic area. blood glucose test , blood pressure monitoring , patient medication review, smoking cessation) should be displayed clearly inside the premises. Name tag with the word "Pharmacist".

Community Pharmacies 52

Community Pharmacies Health and Personal Care Stores Documentation Independent Pharmacies 52

pharmaphorum

MAY 10, 2022

The FDA awarded a fast-track designation to lecanemab in December and has also given the drug breakthrough tag as a treatment for early-stage Alzheimer’s, and Biogen and Eisai will be hoping the drug can sidestep the controversy that engulfed Aduhelm from the moment it was approved.

40

40

Citus Health Specialty Pharmacy

JUNE 10, 2021

96% Of All Patients And Family Caregivers Would Choose One Home Healthcare Provider Over Another Based On The Ability To Respond More Effectively In Real-Time. Referral sources will recognize the higher HHCAHPS scores and have the assurance that the home healthcare provider is investing in patient and family caregiver satisfaction.

Communication 40

Communication HIPAA Hospitals 40

pharmaphorum

NOVEMBER 16, 2022

The advancements made in drug development over the last decade have seen the arrival of a number of treatments that offer one-time cures and more effective therapies for conditions in smaller patient populations. Advanced therapies have changed the treatment landscape for the industry and for patients. However, with a price tag of €1.58

Drug Development 131

Drug Development 131

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Labelling 105

Labelling Data Entry Communication Hospitals 105

Express Pharma

JUNE 28, 2023

As the healthcare sector is redefining its approach to focus on patient comfort, a critical factor to drive patient loyalty is to maintain transparency and agility in the supply chain. Pharmacies must show patients that they prioritise patient health and safety if they want them to choose their pharmacies.

Mail-Order Pharmacies 52

Mail-Order Pharmacies Online Pharmacies 52

pharmaphorum

JUNE 15, 2021

Can the biopharma industry step up again to shatter industry orthodoxy and create new pathways for innovation, access, and affordability? Not surprisingly then, payers feel the pain: increased focus on financial consideration causes friction between pharmacy benefit managers, payers, HCPs and patients. But there is a silver lining.

Vaccines 90

Vaccines 90

European Pharmaceutical Review

MAY 11, 2023

In this Q&A, Dr Sitra Tauscher-Wisniewski, Vice President of Clinical Development & Analytics of Novartis Gene Therapies elaborated on the key findings and discussed the importance of collaboration in fast-tracking access to gene therapies such as Zolgensma. 1 This is assuming a $1M price tag for all gene therapies.

Drug Development 68

Drug Development 68

Pharmaceutical Technology

JANUARY 27, 2023

Before Cablivi’s approval, patients relied on a combination of plasma exchange plus corticosteroids and immunomodulators as the standard of care (SOC) for treatment. Sanofi’s eligibility requirements follow a similar model to Pfizer’s previous programs, with refunds being dependent on lack of clinical outcome in patients.

Documentation 52

Documentation Immunity Immunization Inpatient 52

Viseven

FEBRUARY 6, 2023

Patients and healthcare providers strongly require an individual approach for various reasons like time restrictions or personal specifics. The demand for a more personalized patient experience and better service catalyzes tectonic changes. Of course, this could not leave the pharma market unaffected.

Communication 75

Communication 75

PharmaShots

MARCH 9, 2023

In addition to serving as Associate Editor-in-Chief of the IEEE Open Access Journal of Circuits and Systems, she has been an Associate Editor of IEEE Transactions on Biomedical Circuits and Systems since 2008. Other Affiliations: Alison works as a visiting researcher at Imperial College's Institute of Biomedical Engineering.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

pharmaphorum

NOVEMBER 28, 2022

Owkin is committed to unlocking the vast potential held within patient data by developing technologies that overcome the privacy and security challenges that until now impacted research.”. Owkin in particular has bagged some high-profile, high-price tag development deals with the likes of Bristol-Myers Squibb and Sanofi.

Hospitals 72

Hospitals Drug Development 72

pharmaphorum

OCTOBER 4, 2022

A key part of this initiative was the establishment of the Cancer Moonshot Biobank, which will ask cancer patients to donate biospecimens and associated health information to aid research. The objective is to gather patient biospecimens longitudinally to understand how patients react to treatments and how cancer develops over time.

Documentation 104

Documentation HIPAA Data Entry 104

Pharmacy Joe

JUNE 8, 2022

Vasopressin went from a generic medication with an insignificant cost to a branded product with a brand-name-sized price tag. per patient. This savings was due to using on average 100 units of vasopressin per patient and avoiding the 10 units of waste each time a 50 unit infusion was made from three 20 unit vials.

Hospitals 40

Hospitals Inpatient 40

European Pharmaceutical Review

DECEMBER 27, 2023

Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks. As a result, many patients waiting for the CAR T cells to be infused will need additional therapy (bridging therapy) against the malignance.

Adverse Reactions 81

Adverse Reactions Immunity Immunization Medical Schools 81

Pharmaceutical Technology

NOVEMBER 30, 2022

Previously, the standard of care for obesity consisted of holistic changes to diet, exercise, and bariatric surgery for eligible patients. However, despite the effectiveness of bariatric surgery, many obese patients are reluctant to undergo surgical procedures, opening the opportunity for a pharmaceutical approach. compared to a 5.1%

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Previously, the standard of care for obesity consisted of holistic changes to diet, exercise, and bariatric surgery for eligible patients. However, despite the effectiveness of bariatric surgery, many obese patients are reluctant to undergo surgical procedures, opening the opportunity for a pharmaceutical approach. compared to a 5.1%

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98